−1.98USD
−9.29 MUSD
8.32 M
About Alterity Therapeutics Limited
Sector
CEO
David A. Stamler
Headquarters
Melbourne
Website
Employees (FY)
11
Founded
1997
ISIN
US02155X2053
FIGI
BBG000DK9TP0
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
